Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-17-028595)

Filing Details

Accession Number:: 0000899243-17-028595
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2017-12-13 11:46:00
Reporting Period:: 2017-05-17

Accepted Time:: 2017-12-13 11:46:00
Original Submission Date:: 2017-05-24
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1560241	G1 Therapeutics Inc.	GTHX	()	DE

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1291884	Medimmune Ventures, Inc.	C/O G1 Therapeutics, Inc. 79 T.w. Alexander Drive Research Park Triangle NC 27709		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.0001 Par Value Per Share	Acquisiton	2017-05-17	75,000	$15.00	3,409,536	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

This Form 4 is being amended to reflect the correct transaction date for the purchase of 75,000 shares of common stock of G1 Therapeutics, Inc. on May 17, 2017.